North Korean hackers use AI-deepfakes to target crypto
Homepage > News > Business > Google: North Korean hackers use AI-deepfakes to target crypto Google’s (NASDAQ: GOOGL) cybersecurity firm, […]
February 13, 2026
A Deep Dive Into Its 83% Potential Upside
Rapport Therapeutics, Inc. (NASDAQ: RAPP) is generating significant buzz in the biotechnology sector with its promising pipeline of treatments for
The Direction of Crypto and Big Tech
An AI-powered, automation-driven era is approaching. For automation to become truly autonomous, it must incorporate native payment capabilities. The market
Is RELX (LSE:REL) Now Offering Value After Sharp Share Price Declines?
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Amid a positive outlook, multiple crypto investment institutions complete US$60 million capital injection into Jiuzi Holdings, increasing the original planned amount by 50% Jzxn’s DAT strategy enters scaled implementation phase
Market Closed – Nasdaq 04:00:00 2026-02-12 pm EST 5-day change 1st Jan… Source link
Biotechnology Player With A 60% Upside Potential
As a relatively new entrant in the healthcare sector, Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology
Why Bitcoin, Ethereum, XRP price action is choppy?
Bitcoin (BTC) holds above support at $65,118 at the time of writing on Friday. The Crypto King shows subtle signs
A Biotech With A 60.79% Potential Upside
MBX Biosciences, Inc. (MBX) is making waves in the biotechnology sector with its focus on precision peptide therapies aimed at
crypto today: Why are Bitcoin, Ethereum and XRP prices down today and will crypto market continue to fall or bounce back? BTC USD, ETH crash, analysts insights and market outlook explained. Here’s what should investors do now
Why are Bitcoin, Ethereum and XRP prices down today and will crypto market continue to fall or bounce back? Bitcoin,
Insperity Stock Price Decreases 18% After Reporting Loss in Q4
Insperity, Inc. NSP reported lower-than-expected fourth-quarter 2025 results. The stock has dipped 18.2% since the earnings release on Feb. 10 in